Join Us for an Exclusive Networking Breakfast & Investor Panel Discussion
Are you a female or nonbinary founder looking to navigate the complex world of fundraising? We invite you to an exclusive panel discussion hosted by Foundess, Foley & Lardner, and Girls Into VC on how to approach fundraising and funding strategies. This event will feature insights and advice from seasoned investors, successful founders, and legal counsel providing invaluable guidance for your entrepreneurial journey.
What To Expect
- Investor Panel: Join us for a fundraising panel with incredible female investors in the Boston ecosystem. Our panel will cover how investors evaluate early stage startups, common pitfalls, tips for preparing for investor meetings, metrics to know and track, relationship-building and investor contact strategies, and more!
- Samara Gordon – Investor @Hyperplane VC
- Gabrielle McCarthy – Investor @Underscore VC
- Jadyn Bryden – Investor @XFund
- Networking Opportunity: Meet fellow founders, gain insights from industry experts, and share your experiences. Don’t miss out on this chance to elevate your fundraising strategy and take your startup to the next level
- Light Coffee & Breakfast: Grab a bite and coffee while connecting with other ambitious founders in a supportive environment.
People
Related Insights
April 10, 2026
Energy Current
Proposed Legislation Pending in Oklahoma State Legislature Would Impact Responsibility for Payment of Costs Associated with Data Centers and Other Large Load Facilities
Several proposed bills targeting data centers have been proposed in the 2026 session of the Oklahoma State Legislature. Most of these…
April 9, 2026
Health Care Law Today
Hemp Product Use in Medicare: CMS Greenlights Pilot Program under the Substance Access Beneficiary Engagement Incentive
On April 1, 2026, the Centers for Medicare & Medicaid Services (CMS), through the CMS Innovation Center (CMMI), officially launched a new pilot program which allows participants in specific CMS programs to offer eligible hemp products to eligible Medicare beneficiaries.
April 9, 2026
PharmaPatents
USPTO to Take a Piercing Look at National Stage Applications
USPTO’s PIER pilot program adds a new “confirm‑to‑proceed” step for selected U.S. national stage applications. The PIER program may increase costs, cause delays, and reduce patent term adjustment (PTA). The USPTO may benefit by reducing its workload without refunding examination fees.